CTEV
Claritev Corporation NYSE Listed Apr 3, 2020$26.47
After hrs
$26.47
+0.00%
Mkt Cap $449.1M
52w Low $12.04
23.3% of range
52w High $74.07
50d MA $18.20
200d MA $40.28
P/E (TTM)
-1.4x
EV/EBITDA
11.2x
P/B
—
Debt/Equity
-26.6x
ROE
163.5%
P/FCF
-57.2x
RSI (14)
—
ATR (14)
—
Beta
0.54
50d MA
$18.20
200d MA
$40.28
Avg Volume
188.7K
About
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | AMC | 0.85 | -4.88 | -674.1% | 23.23 | -0.9% | -41.6% | -36.2% | -39.0% | -42.0% | -37.9% | — |
| Nov 7, 2025 | AMC | -3.12 | -4.07 | -30.4% | 69.25 | +4.9% | -16.5% | -17.3% | -15.4% | -36.2% | -37.5% | — |
| Aug 6, 2025 | AMC | -2.69 | 0.32 | +111.9% | 51.14 | -0.3% | +7.4% | +11.1% | +20.5% | +28.5% | +37.6% | — |
| May 8, 2025 | AMC | -2.20 | -3.43 | -55.9% | 21.58 | -0.4% | +0.4% | +1.1% | +16.0% | +24.5% | +26.7% | — |
| Feb 25, 2025 | AMC | -9.81 | -5.14 | +47.6% | 19.61 | -0.7% | +19.9% | +18.1% | +7.0% | -1.8% | -1.8% | — |
| Nov 5, 2024 | AMC | -2.37 | -1.85 | +21.9% | — | — | — | — | — | — | — | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 | Barclays | Initiates | Overweight | $28 | $20.30 | $22.54 | +11.0% | +17.3% | +19.3% | +15.7% | +13.6% | +19.9% |
| Mar 19 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $16.28 | $15.70 | -3.6% | -5.8% | -8.5% | -5.1% | -5.7% | -4.6% |
| Feb 25 | Citigroup | Maintains | Buy → Buy | — | $13.57 | $13.54 | -0.2% | +9.2% | +4.4% | -0.7% | +6.3% | +24.6% |
| Feb 24 | Guggenheim | Maintains | Buy → Buy | — | $23.23 | $23.01 | -0.9% | -41.6% | -36.2% | -39.0% | -42.0% | -37.9% |
| Feb 24 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $23.23 | $23.01 | -0.9% | -41.6% | -36.2% | -39.0% | -42.0% | -37.9% |
| Jan 9 | Citigroup | Maintains | Buy → Buy | — | $31.21 | $30.01 | -3.8% | -7.3% | +2.4% | +3.9% | -2.4% | -3.7% |
| Nov 10 | Citigroup | Maintains | Buy → Buy | — | $69.25 | $72.67 | +4.9% | -16.5% | -17.3% | -15.4% | -36.2% | -37.5% |
| Oct 22 | Citigroup | Upgrade | Neutral → Buy | — | $66.00 | $66.03 | +0.0% | +0.1% | +0.6% | +5.6% | +8.1% | +7.8% |
| Oct 21 | Citigroup | Upgrade | Neutral → Buy | — | $58.52 | $63.08 | +7.8% | +12.8% | +12.9% | +13.5% | +19.1% | +21.9% |
| Aug 15 | Piper Sandler | Maintains | Overweight → Overweight | — | $67.81 | $69.94 | +3.1% | +5.6% | +6.5% | -0.2% | -2.6% | +1.3% |
Recent Filings
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
This vague boilerplate disclosure lacks material information, suggesting the company may be avoiding substantive announcements or facing uncertainty it prefers not to detail to investors.
Mar 16
8-K · 8.01
!! High
Claritev Corporation -- 8-K 8.01: Material Event / Announcement
Claritev Corporation's board authorized a $75 million share repurchase program for its Class A common stock, signaling management confidence while potentially supporting stock price and earnings per share.
Feb 23
Data updated apr 25, 2026 3:40am
· Source: massive.com